Menopause, sleep disruption, vasomotor symptoms, insulin resistance, body-composition changes, thyroid dysfunction, low testosterone, and chronic stress signaling can all influence how patients feel, recover, move, sleep, and maintain metabolic health
Conclusion This meta-analysis suggests that GLP-1RAs, beyond their metabolic benefits, are associated with reduced risks of AUD
liraglutide: Head-to-head study reveals a diabetes risk difference Probiotic strains, such as Akkermansia muciniphila and Lactobacillus species, have been linked to improvements in gut barrier function, systemic inflammation, and metabolic markers
These analytical methods detect contaminants and verify molecular structure
TA664: Liraglutide for managing overweight and obesity